Cargando…
Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling
BACKGROUND: Autoimmune disorders, including Systemic Lupus Erythematosus (SLE), are associated with increased incidence of hematological malignancies. The matricellular protein osteopontin (OPN) has been linked to SLE pathogenesis, as SLE patients show increased serum levels of OPN and often polymor...
Autores principales: | Rizzello, Celeste, Cancila, Valeria, Sangaletti, Sabina, Botti, Laura, Ratti, Chiara, Milani, Matteo, Dugo, Matteo, Bertoni, Francesco, Tripodo, Claudio, Chiodoni, Claudia, Colombo, Mario P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743519/ https://www.ncbi.nlm.nih.gov/pubmed/36503430 http://dx.doi.org/10.1186/s12943-022-01687-6 |
Ejemplares similares
-
SPARC regulation of PMN clearance protects from pristane-induced lupus and rheumatoid arthritis
por: Sangaletti, Sabina, et al.
Publicado: (2021) -
Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
por: Cascini, Caterina, et al.
Publicado: (2023) -
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
por: Mauri, Giorgio, et al.
Publicado: (2015) -
Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies
por: Sangaletti, Sabina, et al.
Publicado: (2014) -
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces
por: Sangaletti, Sabina, et al.
Publicado: (2020)